Sort   by:  
 Page size 
UnknownPreclinical human models and emerging therapeutics for advanced systemic mastocytosis.
Not available
S-EPMC6278969 | biostudies-literature
UnknownDrug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.
Not available
S-EPMC6037300 | biostudies-literature
UnknownHow Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5.
Not available
S-EPMC4696835 | biostudies-literature
UnknownDivergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions.
Not available
S-EPMC6593472 | biostudies-literature
UnknownFrench guidelines for the management of nonadvanced mastocytosis in adults.
Not available
S-EPMC12492810 | biostudies-literature
UnknownFedratinib and gandotinib induce apoptosis and enhance the efficacy of tyrosine kinase inhibitors in human mast cells.
Not available
S-EPMC11815366 | biostudies-literature
UnknownTrispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells.
Not available
S-EPMC6039654 | biostudies-literature
UnknownSingle-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis.
Not available
S-EPMC6557764 | biostudies-literature
UnknownHigher levels of basal serum tryptase are associated with sensitization, FeNO, allergic morbidity, and lower control of allergic asthma in teenagers from the PARIS birth cohort.
Not available
S-EPMC11804298 | biostudies-literature
UnknownClinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis.
Not available
S-EPMC7795405 | biostudies-literature
Sort   by:  
 Page size